Hesperidin market was valued at USD 105 million in 2024 and is projected to reach USD 171 million by 2031, reflecting a CAGR of 7.4% during the forecast period. The market growth is driven by the rising demand for high-purity hesperidin in pharmaceutical formulations, increasing adoption in nutraceuticals and dietary supplements, and expanding research on its therapeutic properties for vascular health, anti-inflammatory, and antioxidant applications. Hesperidin, a bioactive flavonoid primarily sourced from citrus peels, plays a critical role in preventive healthcare and innovative drug development, making it a pivotal ingredient in the healthcare and life sciences sector.
Claim a Free Insight Sample https://www.24lifesciences.com/download-sample/6884/hesperidin-market
Market Highlights: Segmentation and Growth Drivers
By Type
The 93%-98% purity type dominates the market due to its superior efficacy in pharmaceutical applications. Its high flavonoid content ensures optimal therapeutic performance, particularly in cardiovascular and anti-inflammatory drugs. The 90%-92% type is also widely used in dietary supplements and functional foods, while other grades serve general-purpose applications. Continuous innovation in extraction and purification processes supports higher yields and consistent quality, driving growth in premium pharmaceutical-grade hesperidin.
By Application
Pharmaceutical intermediates represent the leading application segment, fueled by hesperidin’s proven role in improving vascular health and reducing blood vessel fragility. Its applications in antihypertensive and arteriosclerosis treatments create consistent demand from pharmaceutical manufacturers. The food sector benefits from hesperidin as a natural antioxidant and nutraceutical ingredient, while other applications include cosmetics and dietary supplements.
By End User
Pharmaceutical companies remain the primary end users, leveraging high-purity hesperidin for drug formulation and clinical applications. Nutraceutical and dietary supplement manufacturers are rapidly adopting hesperidin to capitalize on growing consumer awareness of preventive health, while food and beverage companies utilize it for functional foods and beverages. Increasing regulatory focus on ingredient quality and bioactivity further strengthens demand from pharmaceutical sectors.
By Purity Demand
High-purity pharmaceutical grade leads due to its necessity in medical applications, ensuring consistent efficacy and compliance with pharmacopoeia standards. Standard grades are primarily used in supplements and food, while technical grades cater to research and industrial applications.
By Sourcing Origin
Citrus peel extract dominates as the most commercially viable and sustainable source of hesperidin. Citrus pulp extract and synthetic/biosynthetic sources are used selectively based on application and cost considerations. The preference for natural, plant-derived ingredients continues to drive demand for citrus-sourced hesperidin.
Explore the Full Market Report https://www.24lifesciences.com/hesperidin-market-6884
Emerging Trends Shaping the Healthcare Market
The integration of precision nutrition, functional foods, and bioactive compounds in healthcare is reshaping market demand. Advances in biotechnology, high-purity extraction methods, and sustainable sourcing are enhancing product efficacy and quality. Growing interest in plant-derived natural ingredients and regulatory support for nutraceutical development are further accelerating hesperidin adoption globally.
Regional Analysis
North America leads due to high pharmaceutical R&D investment, awareness of vascular health, and established nutraceutical markets. Europe benefits from regulatory support for natural health products, particularly in Germany, France, and the UK. Asia-Pacific presents significant growth opportunities, driven by expanding pharmaceutical manufacturing, increasing preventive healthcare adoption, and rising citrus production in China, India, and Japan. Latin America and Middle East & Africa are emerging markets, fueled by growing healthcare infrastructure and demand for natural therapeutic ingredients.
Key Players & Competitive Landscape
The market is moderately fragmented with leading companies focusing on product quality, high-purity extracts, and sustainable sourcing. Key players profiled include:
- Zhejiang Conler Pharmaceutical
- Chengdu Okay
- Hunan Kang Biotech
- Sichuan Xieli Pharmaceutical
- Shaanxi Huifeng Pharmaceutical
- Chengdu Shuxi Pharmaceutical
- Hunan Yuantong Pharmaceutical
- Chengdu Yazhong Bio-pharmaceutical
- Chengdu Runde Pharmaceutical
- Hunan Kingti Bio-Tech
- BENEPURE Corporation
- Chengdu Hawk Bio-Engineering
- YAAN TIMES BIOTECH
- Jiaherb
- SANREN Bio-Technology
These companies compete through R&D innovation, new product launches, strategic partnerships, and geographic expansion, strengthening their market position and meeting the rising global demand for high-purity hesperidin.
Explore the Full Market Report https://www.24lifesciences.com/hesperidin-market-6884
Growth Outlook
The global hesperidin market is poised for steady growth through 2032, supported by innovations in pharmaceutical applications, nutraceutical integration, and sustainable extraction technologies. Rising preventive healthcare awareness, coupled with stringent quality requirements, ensures sustained market expansion and profitable opportunities for key players and new entrants alike.
Explore our related reports
About 24lifesciences
Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market
International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)
Website: www.24lifesciences.com
Follow us on LinkedIn: www.linkedin.com/company/lifesciences24
- Single-Domain Heavy Chain Antibody Market - 2026-01-23
- Qianlie Antong Capsules Market - 2026-01-23
- Veterinary Amitraz Solution Market - 2026-01-23